Tandem Financial LLC Purchases New Position in Danaher Corporation $DHR

Tandem Financial LLC purchased a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 10,242 shares of the conglomerate’s stock, valued at approximately $7,375,000. Danaher accounts for about 2.2% of Tandem Financial LLC’s portfolio, making the stock its 11th largest holding.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC boosted its stake in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares in the last quarter. First Trust Advisors LP increased its position in shares of Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after purchasing an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC lifted its holdings in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares during the last quarter. Ieq Capital LLC lifted its holdings in shares of Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC boosted its position in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $215.18 on Tuesday. The stock has a market capitalization of $151.27 billion, a PE ratio of 38.22, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock’s 50-day moving average price is $196.49 and its 200 day moving average price is $192.39. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 EPS. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on DHR. Wells Fargo & Company dropped their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. TD Cowen lowered their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Finally, Royal Bank Of Canada upped their price target on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.